Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market Rivaroxaban Tablets USP, 2.5 mg, which is equivalent to Janssen Pharmaceuticals Inc.’s XARELTO®.

Rivaroxaban 2.5 mg tablets from Lupin and Taro are now considered therapeutic equivalents to name-brand rivaroxaban (Xarelto) ...

Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the ...

The US regulator has cleared 2.5mg tablet formulations of rivaroxaban – the active ingredient in Xarelto – from Sun Pharma subsidiary Taro Pharmaceuticals and Lupin, according to the Orange ...

to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug Xarelto 2.5 mg of Janssen ...

Biocon Pharma has received US FDA approvals for Lenalidomide capsules and Dasatinib tablets, with tentative approval for Rivaroxaban tablets. Coforge has partnered with Sabre Corporation to ...

Half of renally-cleared rivaroxaban is cleared as unchanged drug and half as inactive metabolites. ‡Potent inhibitors of both CYP3A4 and P-gp include azole antifungals (e.g., ketoconazole ...

• Rivaroxaban is indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation • It is used for preventing deep vein thrombosis (DVT), which ...

Earlier this April, Aurobindo had also received USFDA approval for the manufacture and marketing of Rivaroxaban Tablets USP, 2.5mg, a generic equivalent of Xarelto 2.5mg of Janssen Pharmaceuticals.